| 2927.00.18 | 00 | 1-Naphthalenesulfonic acid, 6-diazo-5,6-dihydro-5-oxo, ester with phenyl(2,3,4-trihydroxyphenyl)methanone; 1-Naphthalenesulfonic acid, 3-diazo-3,4-dihydro-4- oxo-ar'-(1-methylethyl)[1,1'-biphenyl]-4-yl ester; 1-Napthanlenesulfonic acid, 6-diazo-5,6-dihydro-5- oxo-,(octahydro-4,7-methano-1H-indene-2,5-diyl)bis- (methylene) ester; and 1-Naphthalenesulfonic acid, 6-diazo-5,6-dihydro-5- oxo-, 4-benzoyl-1,2,3-benzenetriyl ester | kg | Free | | 15.4¡é/kg + 50% |
| 2929.90.50 | 10 | N,N-Dialkyl (methyl, ethyl, n-propyl or isopropyl)phosphoramidic dihalides | kg | | | |
| 2929.90.50 | 20 | Dialkyl (methyl, ethyl, n-propyl or isopropyl)-N,N-dialkyl (methyl, ethyl, n-propyl or isopropyl)phosphoramidates | kg | | | |
| 2930.90.91 | 23 | N,N-Dialkyl (methyl, ethyl, n-propyl or isopropyl)aminoethane-2-thiols and their protonated salts | kg | | | |
| 2933.33.00 | 00 | Alfentanil (INN), anileridine (INN), bezitramide (INN), bromazepam (INN), difenoxin (INN), diphenoxylate (INN), dipipanone (INN), fentanyl (INN), ketobemidone (INN), methylphenidate (INN), pentazocine (INN), pethidine (INN), pethidine (INN) intermediate A, phencyclidine (INN) (PCP), phenoperidine (INN), pipradrol (INN), piritramide (INN), propiram (INN) and trimeperidine (INN); salts thereof | kg | Free | | 15.4¡é/kg + 149.5% |
| 2933.39.08 | 00 | 1-(3-Sulfopropyl)pyridinium hydroxide; N,N'-Bis(2,2,6,6-tetramethyl-4-piperidinyl)-1,6- hexanediamine; 3,5-Dimethyl-2-hydroxymethyl-4-methoxy- pyridine (pyrmethyl alcohol); Dipentamethylenethiuram tetrasulfide; 2H-Indol-2-one,1,3-dihydro-1-phenyl-3-(4- pyridinylmethylene); 4-Picolyl chloride hydrochloride; and Piperidinoethyl chloride hydrochloride | kg | Free | | 15.4¡é/kg + 52% |
| 2933.69.20 | 00 | 2,4-Diamino-6-phenyl-1,3,5-triazine | kg | Free | | 25% |
| 2933.91.00 | 00 | Alprazolam (INN), camazepam (INN), chlordiazepoxide (INN), clonazepam (INN), clorazepate, delorazepam (INN), diazepam (INN), estazolam (INN), ethyl loflazepate (INN), fludiazepam (INN), flunitrazepam (INN), flurazepam (INN), halazepam (INN), lorazepam (INN), lormetazepam (INN), mazindol (INN), medazepam (INN), midazolam (INN), nimetazepam (INN), nitrazepam (INN), nordazepam (INN), oxazepam (INN), pinazepam (INN), prazepam (INN), pyrovalerone (INN), temazepam (INN), tetrazepam (INN) and triazolam (INN); salts thereof | kg | Free | | 15.4¡é/kg + 149.5% |
| 2934.99.03 | 00 | 2-Acetylbenzo(b)thiophene; 3-Methylene-7-(2-phenoxyacetamido)- cephan-4-carboxylic acid, p-nitrobenzyl ester, 1-oxide; and Naphth[1,2-d]-[1,2,3]-oxadiazole-5-sulfonic acid and its sodium salt | kg | Free | | 15.4¡é/kg + 52% |
| 2934.99.05 | 00 | 5-Amino-3-phenyl-1,2,4-thiadiazole (3-Phenyl-5-amino-1,2,4-thiadiazole); 2-Hydroxybenzoxazole (Benzoxazolone); 4-Phenylmorpholine; 1,9-Thianthrenedicarboxylic acid; and Thioxanthene-9-one (Thioxanthone) | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 15.4¡é/kg + 39.5% |
| 2934.99.06 | 00 | 7-Nitronaphth[1,2]oxadiazole-5-sulfonic acid and its salts | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,L,MA,MX, P,SG) | 15.4¡é/kg + 66.5% |
| 2934.99.11 | 00 | 2-tert-Butyl-4-(2,4-dichloro-5- isopropoxyphenyl)- 2-1,3,4- oxadiazolin-5-one; 3-Isopropyl-1H-2,1,3- benzothiadiazin-4-(3H)-one-2,2- dioxide (Bentazon); and O,O-Diethyl-S-[(6-chloro-2- oxobenzoxazolin-3-yl)methyl]¡é/phosphorodithioate (Phosalone) | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4¡é/kg + 40.5% |
| 2935.00.42 | 00 | Salicylazosulfapyridine (Sulfasalazine); Sulfadiazine; Sulfaguanidine; Sulfamerizine; and Sulfapyridine | kg | Free | | 15.4¡é/kg + 128.5% |
| 2939.51.00 | 00 | Theophylline and aminophylline (theophylline- ethylenediamine) and their derivatives; salts thereof: | | | | |
| 3002 | | Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products: | | | | |
| 3006.30 | | Opacifying preparations for X-ray examinations; diagnostic reagents designed to be administered to the patient: | | | | |
| 3105.30.00 | 00 | Diammonium hydrogenorthophosphate (Diammonium phosphate) | t | Free | | Free |
| 3105.40.00 | | Ammonium dihydrogenorthophosphate (Mono- ammonium phosphate) and mixtures thereof with diammonium hydrogenorthophosphate (Diammonium phosphate) | | Free | | Free |
| 3212 | | Pigments (including metallic powders and flakes) dispersed in nonaqueous media, in liquid or paste form, of a kind used in the manufacture of paints (including enamels); stamping foils; dyes and other coloring matter put up in forms or packings for retail sale: | | | | |
| 3812.30.20 | 00 | Mixtures of N,N'-diaryl-p-phenylenediamines | kg | 6.5% | Free (A,AU,BH, CA,CL,E,IL,J,JO, MA,MX, P,SG) | 3.7¡é/kg + 60% |
| 3821.00.00 | 00 | Prepared culture media for development or maintenance of micro-organisms (including viruses and the like) or of plant, human or animal cells | kg | 5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 25% |
| 3822.00 | | Diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents, whether or not on a backing, other than those of heading 3002 or 3006; certified reference materials: | | | | |
| 3822.00.10 | | Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents, whether or not on a backing, other than those of heading 3002 or 3006: | | | | |
| 4011.10.10 | | Radial | | 4% | Free (A*,AU,BH, CA,E,IL,J,JO, MA,MX,P,SG) See 9911.40.05 9911.40.10 (CL) | 10% |
| 4011.10.10 | 10 | Having a rim diameter of 33.02 cm (13 inches) or less | No. | | | |
